EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C16H19FN2O3S |
| Net Charge | 0 |
| Average Mass | 338.404 |
| Monoisotopic Mass | 338.11004 |
| SMILES | Cc1nc(C2CCCCC2)c(-c2ccc(S(N)(=O)=O)c(F)c2)o1 |
| InChI | InChI=1S/C16H19FN2O3S/c1-10-19-15(11-5-3-2-4-6-11)16(22-10)12-7-8-14(13(17)9-12)23(18,20)21/h7-9,11H,2-6H2,1H3,(H2,18,20,21) |
| InChIKey | MIMJSJSRRDZIPW-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | cyclooxygenase 2 inhibitor A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 2. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| tilmacoxib (CHEBI:73041) has role cyclooxygenase 2 inhibitor (CHEBI:50629) |
| tilmacoxib (CHEBI:73041) is a 1,3-oxazoles (CHEBI:46812) |
| tilmacoxib (CHEBI:73041) is a organofluorine compound (CHEBI:37143) |
| tilmacoxib (CHEBI:73041) is a sulfonamide (CHEBI:35358) |
| IUPAC Name |
|---|
| 4-(4-cyclohexyl-2-methyl-1,3-oxazol-5-yl)-2-fluorobenzenesulfonamide |
| INNs | Source |
|---|---|
| tilmacoxib | WHO MedNet |
| tilmacoxib | WHO MedNet |
| tilmacoxibum | WHO MedNet |
| tilmacoxib | WHO MedNet |
| Synonyms | Source |
|---|---|
| 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide | ChemIDplus |
| JTE-522 | ChemIDplus |
| JTP-19605 | ChemIDplus |
| 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo(4,5)imidazo(1,2a)pyridine-4-N-(2-fluorophenyl)carboxamide | ChemIDplus |
| RWJ-57504 | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| Tilmacoxib | Wikipedia |
| D01974 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| Reaxys:9005354 | Reaxys |
| CAS:180200-68-4 | KEGG DRUG |
| CAS:180200-68-4 | ChemIDplus |
| Citations |
|---|